Revised SPCs: DHC Continus (dihydrocodeine tartrate) prolonged release tablets – all strengths

SPC updated to include additional warnings of drug dependence, tolerance, potential for abuse, drug withdrawal syndrome, hyperalgesia, neonatal withdrawal syndrome & respiratory depression in newborns. Statement regarding requirement for strategy for treatment cessation added.

electronic Medicines compendium